2015Chin J Thorac Surg(Electronic Edition)Requires access

Clinical characteristics and prognostic analysis of lung adenocarcinoma

Weigui Yang, Hualing Ma

Open publisher page 0 citations

Abstract

Objective To investigate the clinicopathological characteristics and prognosis of lung adenocarcinoma undergoing resection, and explore the its prognostic factors. Methods The clinical data of 109 cases of lung adenocarcinoma undergoing resection were retrospectively reviewed. Univariate analysis of clinicopathological characteristics was performed, and the statistically significant factors were included in multivariate analysis. Results For the 109 cases of lung adenocarcinoma, the overall 5-year survival was 44.0%(48/109). Univariate analysis revealed that tumor size(χ2=8.995, P=0.003), lymph node status(χ2=12.727, P=0.0000), TNM stage(χ2=39.544, P=0.000), surgical margin(χ2=35.551, P=0.000)and expression of PCNA(χ2=5.441, P=0.020) influenced survival time. Multivariate analysis indicated that tumor size, TNM stage, and surgical margin were independent prognostic factors of lung adenocarcinoma (P<0.05), and postoperative chemotherapy was prognostic factors of stageⅡ and Ⅲ lung adenocarcinoma(χ2=11.299, P=0.001). Conclusion Tumor size, higher TNM stage and positive surgical margin may be important factors of unfavorable prognosis of lung adenocarcinoma, and patients with stage Ⅱ and Ⅲ lung adenocarcinoma may gain benefits from postoperative adjuvant chemotherapy. Key words: Lung neoplasm; Lung adenocarcinoma; Univariate analysis; Multivariate analysis; prognosis

About this research paper

What this paper is about

Objective To investigate the clinicopathological characteristics and prognosis of lung adenocarcinoma undergoing resection, and explore the its prognostic factors. Methods The clinical data of 109 cases of lung adenocarcinoma undergoing resection were retrospectively reviewed. Univariate analysis of clinicopathological characteristics was performed, and the statistically significant factors were included in multivariate analysis. Results For the 109 cases of lung adenocarcinoma, the overall 5-year survival was 44.0%(48/109). Univariate analysis revealed that tumor size(χ2=8.995, P=0.003), lymph node status(χ2=12.727, P=0.0000), TNM stage(χ2=39.544, P=0.000), surgical margin(χ2=35.551, P=0.000)and expression of PCNA(χ2=5.441, P=0.020) influenced survival time. Multivariate analysis indicated that tumor size, TNM stage, and surgical margin were independent prognostic factors of lung adenocarcinoma (P<0.05), and postoperative chemotherapy was prognostic factors of stageⅡ and Ⅲ lung adenocarcinoma(χ2=11.299, P=0.001). Conclusion Tumor size, higher TNM stage and positive surgical margin may be important factors of unfavorable prognosis of lung adenocarcinoma, and patients with stage Ⅱ and Ⅲ lung adenocarcinoma may gain benefits from postoperative adjuvant chemotherapy. Key words: Lung neoplasm; Lung adenocarcinoma; Univariate analysis; Multivariate analysis; prognosis

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinicopathological characteristics and prognosis of lung adenocarcinoma undergoing resection, and explore the its prognostic factors. Methods The clinical data of 109 cases of lung adenocarcinoma undergoing resection were retrospectively reviewed. Univariate analysis of clinicopathological characteristics was performed, and the statistically significant factors were included in multivariate analysis. Results For the 109 cases of lung adenocarcinoma, the overall 5-year survival was 44.0%(48/109). Univariate analysis revealed that tumor size(χ2=8.995, P=0.003), lymph node status(χ2=12.727, P=0.0000), TNM stage(χ2=39.544, P=0.000), surgical margin(χ2=35.551, P=0.000)and expression of PCNA(χ2=5.441, P=0.020) influenced survival time. Multivariate analysis indicated that tumor size, TNM stage, and surgical margin were independent prognostic factors of lung adenocarcinoma (P<0.05), and postoperative chemotherapy was prognostic factors of stageⅡ and Ⅲ lung adenocarcinoma(χ2=11.299, P=0.001). Conclusion Tumor size, higher TNM stage and positive surgical margin may be important factors of unfavorable prognosis of lung adenocarcinoma, and patients with stage Ⅱ and Ⅲ lung adenocarcinoma may gain benefits from postoperative adjuvant chemotherapy. Key words: Lung neoplasm; Lung adenocarcinoma; Univariate analysis; Multivariate analysis; prognosis

Key concepts: Adenocarcinoma, Medicine, Univariate analysis, Stage (stratigraphy), Multivariate analysis, Resection margin, Internal medicine, Lung

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical characteristics and prognostic analysis of lung adenocarcinoma — Research Paper | ScholarLens